Stem Point Capital LP Roivant Sciences Ltd. Transaction History
Stem Point Capital LP
- $314 Billion
- Q1 2025
A detailed history of Stem Point Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Stem Point Capital LP holds 2,578,860 shares of ROIV stock, worth $29.6 Million. This represents 8.29% of its overall portfolio holdings.
Number of Shares
2,578,860
Previous 2,712,778
4.94%
Holding current value
$29.6 Million
Previous $32.1 Billion
18.92%
% of portfolio
8.29%
Previous 8.01%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
349Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$756 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$711 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$529 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$468 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$413 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.09B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...